Reply: Some Questions on the Study of Renin-Angiotensin System Inhibition Following Transcatheter Aortic Valve Replacement

In response to the letter from Dr. Tang and Dr. Zhou, we thank them for their interest in our study on the impact of renin-angiotensin system inhibition in patients following transcatheter aortic valve implantation ([1][1]). However, we respectfully disagree with some aspects. First, they argue